Prodrug strategies to enhance the intestinal absorption of peptides
- 30 April 1997
- journal article
- review article
- Published by Elsevier BV in Drug Discovery Today
- Vol. 2 (4), 148-155
- https://doi.org/10.1016/s1359-6446(97)01011-8
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Structural requirements for intestinal absorption of peptide drugsJournal of Controlled Release, 1996
- Absorption of Peptide and Peptidomimetic DrugsAnnual Review of Pharmacology and Toxicology, 1994
- Overcoming enzymatic and absorption barriers to non-parenterally administered protein and peptide drugsJournal of Controlled Release, 1994
- Pharmacokinetics and pharmacodynamics of recombinant proteins and peptidesJournal of Controlled Release, 1994
- Quantification and Visualization of the Transport of Octreotide, a Somatostatin Analogue, Across Monolayers of Cerebrovascular Endothelial CellsPharmaceutical Research, 1994
- Enteral absorption of octreotide: absorption enhancement by polyoxyethylene‐24‐cholesterol etherBritish Journal of Pharmacology, 1993
- Passive Transepithelial Absorption of Thyrotropin-Releasing Hormone (TRH) via a Paracellular Route in Cultured Intestinal and Renal Epithelial Cell LinesPharmaceutical Research, 1993
- Penetration and enzymatic barriers to peptide and protein absorptionAdvanced Drug Delivery Reviews, 1989
- Peptides and Related Drugs: A Review of Their Absorption, Metabolism, and ExcretionDrug Metabolism Reviews, 1986
- Intestinal transport of dipeptides in man: relative importance of hydrolysis and intact absorptionJCI Insight, 1971